Category: Research

UW-Madison announced Tuesday that scientists from the university and the Morgridge Institute for Research have been able to capture “strikingly improved images” of a virus group, which could help aid in the creation of antiviral drugs and treatment for COVID-19.

If this whole smart glasses thing is going to effectively free us from having our heads constantly down and staring at our phones, we’re going to need a reliable way to interact with a virtual screen. Thanks to new research from Cornell University and the University of Wisconsin, Madison, we could still rely on our hands and fingers without actually having to touch a screen.

The team of researchers, including chemists from the University of Wisconsin-Madison and their collaborators, have created a highly efficient and long-lasting solar flow battery. The device can generate, store, and redeliver renewable electricity from the sun in one device. The device consists of silicon solar cells combined with advanced solar materials.

A team of UW-Madison engineers and local manufacturers is working together again to improve PPE options for health care workers. But their new face shield is also in high demand with schools across the country as they get ready to reopen.

The school will use UW Health as a trial site to test an “antibody cocktail” developed by Regeneron Pharmaceuticals, a company based in New York. Researchers are calling the treatment “REGN-COV2.”

The University of Wisconsin School of Medicine and Public Health and UW Health will conduct three clinical trials to test a new treatment and preventative for COVID-19, in collaboration with Regeneron Pharmaceuticals.

Some of the most critical COVID-19 research is being done right here in Wisconsin as there is still much to learn about the virus. New clinical trials are testing treatment and preventative measures. Researchers say it could be groundbreaking in the ongoing effort to get a handle of the virus.

That is 40% more efficient than the previous record for solar-flow batteries, which also were developed by Song Jin and colleagues in his lab at the University of Wisconsin-Madison, US.

The solar-flow battery has a 20 percent efficiency rate of converting energy from the sun, setting a new record of efficiency — a 40 percent improvement over the previous solar-flow battery record — according to researchers at the University of Wisconsin-Madison.

Chemists from the Song Jin lab at the University of Wisconsin-Madison said on Tuesday that the new device was made of silicon solar cells combined with advanced solar materials and integrated with optimally designed chemical storage components.

Capturing energy from the Sun with solar panels is only half the story – that energy needs to be stored somewhere for later use. In the case of flow batteries, storage is relegated to vats of liquid. Now, an international team led by University of Wisconsin-Madison scientists has created a new version of these solar flow batteries that’s efficient and long-lasting.

A team of researchers from the University of Wisconsin- Madison conducted a study on a group of 25 healthy employees, who practised meditation for eight weeks.

For covaxin, Bharat Biotech has joined with the National Institute of Virology, which is part of the Indian Council of Medical Research (ICMR). (The company is separately developing COVID-19 vaccine candidates in collaboration with Thomas Jefferson University in Philadelphia and the University of Wisconsin, Madison.)

It should also be noted that the company is simultaneously also engaged in the development of another vaccine called ’Coroflu’ which is being developed in a collaboration with the University of Wisconsin-Madison and vaccine maker FluGen.

The CDC previously awarded more than $10 million to help aid state and local efforts to stem the spread of the disease. Scientists at the University of Wisconsin-Madison have been deeply involved in the search for a vaccine, and hundreds of Wisconsin families are part of a federal study on the role children play in spreading the virus.

New video shows a deep dive into mask protection using a simulated cough test. UW Madison’s Engine Research Center is demonstrating how droplets from a cough travel from inside different styles and materials of masks.

Could your significant other help you lose the weight you’ve gained during the pandemic? That’s the question a UW School of Medicine and Public Health study is looking to answer.

Steve Ackerman’s job overseeing UW-Madison’s behemoth research enterprise officially began March 9. Two days later, his job description changed dramatically when the university announced unprecedented measures it would take to reduce the spread of COVID-19. Instead of finding ways to expand research on campus, Ackerman was now tasked with ramping down most research labs and helping scientists continue their research remotely.

Having secured an approval for human trials, Covaxin has reached a more advanced phase. Not only is BBIL in close contact with locally developed institutes, but they are also in a global collaboration with Thomas Jefferson University and the University of Wisconsin-Madison and vaccine maker FluGen.

Over half of the characters depicted in children’s books are white, according to the statistics compiled in 2018 by the Cooperative Children’s Book Center at the University of Wisconsin-Madison.

How does Covaxin compare to other vaccine candidates around the world? Where does it figure in the global race for a Covid-19 vaccine?

Covaxin has reached a more advanced stage of testing than two other vaccine candidates that Bharat Biotech is developing through global collaborations–the first is in collaboration with Thomas Jefferson University, while the second is with the University of Wisconsin-Madison and vaccine maker FluGen. Both these candidates are currently in the pre-clinical stage, according to the World Health Organisation’s draft landscape of Covid-19 candidate vaccines.

In a new study, researchers from the University of Wisconsin-Madison found that children with an incarcerated parent whose family used resources from the education nonprofit behind “Sesame Street” experienced more positive social-emotional development.

UW Health is part of a new clinical trial working to combat COVID-19 among patients.

Researchers, including Yoshihiro Kawaoka from the University of Wisconsin-Madison in the US, demonstrated that both low and high doses of the novel corovirus, SARS-COV-2 replicate well in the airways of juvenile as well as adult hamsters.

But getting an accurate count isn’t an easy feat — it’s time and resource intensive and only occurs on roughly 5 percent of Wisconsin’s more than 900 walleye lakes, said Mike Spear, a Ph.D student at the University of Wisconsin-Madison Center for Limnology.

All experiments with SARS-CoV-2 were performed in enhanced biosafety level 3 (BSL3) containment laboratories at the University of Tokyo, which are approved for such use by the Ministry of Agriculture, Forestry, and Fisheries, Japan, or in enhanced BSL3 containment laboratories at the University of Wisconsin-Madison, which are approved for such use by the Centers for Disease Control and Prevention and by the US Department of Agriculture.